Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
Cell Biosci
.
2023 Jun 9;13(1):104.
doi: 10.1186/s13578-023-01057-9.
Authors
Tania B López-Méndez
#
1
2
,
Miguel Sánchez-Álvarez
#
3
4
,
Flavia Trionfetti
5
6
,
José L Pedraz
1
2
,
Marco Tripodi
5
6
,
Marco Cordani
#
7
8
,
Raffaele Strippoli
#
9
10
,
Juan González-Valdivieso
#
11
Affiliations
1
NanoBioCel Group, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.
2
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, (CIBER-BBN), Vitoria-Gasteiz, Spain.
3
Area of Cell and Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
4
Instituto de Investigaciones Biomédicas Alberto Sols (IIB), Madrid, Spain.
5
Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.
6
National Institute for Infectious Diseases L. Spallanzani IRCCS, Rome, Italy.
7
Department of Biochemistry and Molecular Biology, School of Biology, Complutense University, Madrid, Spain. mcordani@ucm.es.
8
Instituto de Investigaciones Sanitarias San Carlos (IdISSC), Madrid, Spain. mcordani@ucm.es.
9
Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. raffaele.strippoli@uniroma1.it.
10
National Institute for Infectious Diseases L. Spallanzani IRCCS, Rome, Italy. raffaele.strippoli@uniroma1.it.
11
Molecular Imaging Innovations Institute (MI3), Department of Radiology, Weill Cornell Medicine, New York, USA. juan.gonzalez.valdivieso@uva.es.
#
Contributed equally.
PMID:
37296451
PMCID:
PMC10257261
DOI:
10.1186/s13578-023-01057-9
No abstract available
Publication types
Published Erratum